Matches in SemOpenAlex for { <https://semopenalex.org/work/W2920357183> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W2920357183 abstract "Introduction: Glioblastoma (GBM) is the most common and devastating primary brain tumor. The recurrence rate remains high with a median survival of 15 months. GBM’s infiltrative nature results in ill-defined margins that makes maximal tumor resection with minimal morbidity a challenge. Epidermal growth factor receptor (EGFR) is the most frequently amplified gene in GBM (35-45% of tumors) and is associated with overexpression in about 40-98% of cases, a characteristic of more aggressive phenotypes. We hypothesize that fluorescence labeled anti-EGFR monoclonal antibodies (mAb), panitumumab-IRDye800 (pan800) and cetuximab-IRDye800 (cet800), could be leveraged to enhance tumor contrast during surgical resection and improve patient outcome. Methods: 50mg fluorescently labeled corresponding study drugs, pan800 and cet800 respectively, were administered 1-2 days in glioblastoma patients with contrast enhancing (CE) tumors prior to surgery following 100 mg loading dose of unlabeled cetuximab or panitumumab. Near-infrared fluorescence imaging of tumor and histologically negative peri-tumoral tissue was performed intraoperatively and ex vivo. Fluorescence was measured as mean fluorescence intensity (MFI), and tumor-to-background ratios (TBRs) were calculated by comparing MFIs of tumor and histologically uninvolved tissue.Results: Despite heterogeneous drug uptake across all resected brain tissues, mean fluorescence intensity (MFI) correlated strongly (R^2=0.97) with tumor volume among histologically confirmed tumor tissues. The smallest detectable tumor size in a closed-field setting was 4.2 x 2.7 mm^2 (8.2 mg) for pan800 and 8.5 x 6.6 mm^2 (70mg) for cet800. Tumor tissues from pan800 infusion had significantly higher mean TBR (8.1 ± 4.6) than cet800 infused ones in intraoperative imaging (3.3 ± 2.7; P = 0.004). NIR fluorescence from both test drugs provided high contrast to identify as few as a cluster of (5 ± 1) tumor cells in macroscopic imaging of whole sections of paraffin embedded tissues. Sensitivity and specificity of MFI for viable tumor detection was calculated and fluorescence was found to be highly sensitive (64.4% for pan800, 73.0% for cet800) and specific (98.0% for pan800, 66.3% for cet800) for viable tumor tissue while normal peri-tumoral tissue showed minimal fluorescence. No related grade-2 adverse events were observed 30 days beyond the infusion of either study drugs.Conclusion: EGFR antibody based imaging for contrast-enhanced glioblastomas proved safe in human patients and specific intratumoral delivery of NIR fluorescence provided high optical contrast and resolution for intraoperative image-guided resection. Fully humanized panitumumab-IRDye800 demonstrated superior detection sensitivity and tumor specificity over the chimeric cetuximab-IRDye800." @default.
- W2920357183 created "2019-03-11" @default.
- W2920357183 creator A5004662864 @default.
- W2920357183 creator A5011570359 @default.
- W2920357183 creator A5012203120 @default.
- W2920357183 creator A5031436259 @default.
- W2920357183 creator A5051170836 @default.
- W2920357183 creator A5053679820 @default.
- W2920357183 creator A5055929035 @default.
- W2920357183 creator A5057729645 @default.
- W2920357183 creator A5060770160 @default.
- W2920357183 creator A5078699338 @default.
- W2920357183 creator A5080318012 @default.
- W2920357183 creator A5086275218 @default.
- W2920357183 date "2019-03-04" @default.
- W2920357183 modified "2023-09-26" @default.
- W2920357183 title "fluorescence-guided surgery with panitumumab-IRDye800 and cetuximab-IRDye800 in glioblastoma patients (Conference Presentation)" @default.
- W2920357183 doi "https://doi.org/10.1117/12.2510366" @default.
- W2920357183 hasPublicationYear "2019" @default.
- W2920357183 type Work @default.
- W2920357183 sameAs 2920357183 @default.
- W2920357183 citedByCount "0" @default.
- W2920357183 crossrefType "proceedings-article" @default.
- W2920357183 hasAuthorship W2920357183A5004662864 @default.
- W2920357183 hasAuthorship W2920357183A5011570359 @default.
- W2920357183 hasAuthorship W2920357183A5012203120 @default.
- W2920357183 hasAuthorship W2920357183A5031436259 @default.
- W2920357183 hasAuthorship W2920357183A5051170836 @default.
- W2920357183 hasAuthorship W2920357183A5053679820 @default.
- W2920357183 hasAuthorship W2920357183A5055929035 @default.
- W2920357183 hasAuthorship W2920357183A5057729645 @default.
- W2920357183 hasAuthorship W2920357183A5060770160 @default.
- W2920357183 hasAuthorship W2920357183A5078699338 @default.
- W2920357183 hasAuthorship W2920357183A5080318012 @default.
- W2920357183 hasAuthorship W2920357183A5086275218 @default.
- W2920357183 hasConcept C126322002 @default.
- W2920357183 hasConcept C142724271 @default.
- W2920357183 hasConcept C159654299 @default.
- W2920357183 hasConcept C170493617 @default.
- W2920357183 hasConcept C203014093 @default.
- W2920357183 hasConcept C2776194525 @default.
- W2920357183 hasConcept C2778332735 @default.
- W2920357183 hasConcept C2779130545 @default.
- W2920357183 hasConcept C2779438470 @default.
- W2920357183 hasConcept C2779998722 @default.
- W2920357183 hasConcept C2989005 @default.
- W2920357183 hasConcept C502942594 @default.
- W2920357183 hasConcept C542903549 @default.
- W2920357183 hasConcept C71924100 @default.
- W2920357183 hasConceptScore W2920357183C126322002 @default.
- W2920357183 hasConceptScore W2920357183C142724271 @default.
- W2920357183 hasConceptScore W2920357183C159654299 @default.
- W2920357183 hasConceptScore W2920357183C170493617 @default.
- W2920357183 hasConceptScore W2920357183C203014093 @default.
- W2920357183 hasConceptScore W2920357183C2776194525 @default.
- W2920357183 hasConceptScore W2920357183C2778332735 @default.
- W2920357183 hasConceptScore W2920357183C2779130545 @default.
- W2920357183 hasConceptScore W2920357183C2779438470 @default.
- W2920357183 hasConceptScore W2920357183C2779998722 @default.
- W2920357183 hasConceptScore W2920357183C2989005 @default.
- W2920357183 hasConceptScore W2920357183C502942594 @default.
- W2920357183 hasConceptScore W2920357183C542903549 @default.
- W2920357183 hasConceptScore W2920357183C71924100 @default.
- W2920357183 hasLocation W29203571831 @default.
- W2920357183 hasOpenAccess W2920357183 @default.
- W2920357183 hasPrimaryLocation W29203571831 @default.
- W2920357183 hasRelatedWork W1609648169 @default.
- W2920357183 hasRelatedWork W1975024804 @default.
- W2920357183 hasRelatedWork W2017190688 @default.
- W2920357183 hasRelatedWork W2030239221 @default.
- W2920357183 hasRelatedWork W2055203322 @default.
- W2920357183 hasRelatedWork W2069152342 @default.
- W2920357183 hasRelatedWork W2088819814 @default.
- W2920357183 hasRelatedWork W2342633773 @default.
- W2920357183 hasRelatedWork W2742068309 @default.
- W2920357183 hasRelatedWork W2783677395 @default.
- W2920357183 hasRelatedWork W2795715780 @default.
- W2920357183 hasRelatedWork W2916579470 @default.
- W2920357183 hasRelatedWork W2919657070 @default.
- W2920357183 hasRelatedWork W2943164034 @default.
- W2920357183 hasRelatedWork W2962575358 @default.
- W2920357183 hasRelatedWork W3012844483 @default.
- W2920357183 hasRelatedWork W3038338208 @default.
- W2920357183 hasRelatedWork W3043395208 @default.
- W2920357183 hasRelatedWork W3171582080 @default.
- W2920357183 hasRelatedWork W3207500668 @default.
- W2920357183 isParatext "false" @default.
- W2920357183 isRetracted "false" @default.
- W2920357183 magId "2920357183" @default.
- W2920357183 workType "article" @default.